| 1 |
35267027 | Post hoc Analysis of Clinical Characteristics of Patients with Radiographic Progression in a Japanese phase 3 trial of Peficitinib and Methotrexate Treatment (RAJ4). | 2022 Mar 10 |
1 |
| 2 |
33929089 | Exposure-response modeling of peficitinib efficacy in patients with rheumatoid arthritis. | 2021 May |
3 |
| 3 |
31350270 | Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3). | 2019 Oct |
1 |
| 4 |
27748083 | Peficitinib, a JAK Inhibitor, in the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Patients With an Inadequate Response to Methotrexate. | 2017 Apr |
1 |